NOROCARP 50 MG/ML SOLUTION FOR INJECTION FOR CATTLE
البلد: أيرلندا
اللغة: الإنجليزية
المصدر: HPRA (Health Products Regulatory Authority)
خصائص المنتج
(SPC)
18-12-2014
بعض المستندات الخاصة بهذا المنتج غير متوفرة حاليًا ، يمكنك إرسال طلب إلى خدمة العملاء الخاصة بنا وسوف نخطرك بمجرد أن نتمكن من الحصول عليها.
ارسل طلب
ارسل طلب
العنصر النشط:
CARPROFEN
متاح من:
Norbrook Laboratories Limited
ATC رمز:
QM01AE91
INN (الاسم الدولي):
CARPROFEN
جرعة:
50 Mg/Ml
الشكل الصيدلاني:
Solution for Injection
نوع الوصفة الطبية :
POM
المجموعة العلاجية:
Bovine
المجال العلاجي:
Carprofen
الخصائص العلاجية:
N.S.A.I.D
الوضع إذن:
Authorised
تاريخ الترخيص:
2005-09-09
خصائص المنتج
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Norocarp 50 mg/ml Solution for Injection for Cattle.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Solution for Injection.
A clear colourless to pale yellow solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Reduction of pyrexia in acute cases of infectious respiratory disease in cattle, in combination with appropriate anti-infective
therapy.
4.3 CONTRAINDICATIONS
Do not use in animals suffering from cardiac, hepatic or renal impairment.
Do not use in animals suffering from gastro-intestinal ulceration or bleeding.
Do not use where there is evidence of a blood dyscrasia.
Do not use in animals with known hypersensitivity to the product.
Do not use in pregnant animals refer to section 4.7.
Active substance
Carprofen
50 mg/ml
Excipients
Ethanol (anhydrous)
100 mg/ml
Sodium Formaldehyde Sulphoxylate
2.0 mg/ml
For a full list of excipients, see section 6.1
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 03/12/2014_
_CRN 7019269_
_page number: 1_
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5 SPECIAL PRECAUTIONS FOR USE
I) SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Do not exceed the stated dose or the duration of treatment.
Do not administer other NSAIDs concurrently or within 24 hours of each other. Some NSAIDs may be highly bound to
plasma proteins and compete with other highly bound drugs, which can lead to toxic effects.
Use in any animal less than 6 weeks of age, or in aged animals, may involve additional risk. If such use cannot be avoided
animals may require a reduced dosage and careful clinical management.
Avoid use
اقرأ الوثيقة كاملة
